20:07 EST Cathie Wood’s ARK Investment buys 116K shares of Beam Therapeutics (BEAM) today
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BEAM:
- Editas Medicine downgraded to Equal Weight from Overweight at Wells Fargo
- Beam Therapeutics Advances BEAM-101 Therapy for Sickle Cell
- Beam presents new NHP data demonstrating proof-of-concept for ESCAPE
- Beam Therapeutics announces new data from BEACON Phase 1/2 trial of BEAM-101
- Beam Therapeutics Names Sravan K. Emany as CFO